Temasek could reportedly invest in CureFit at a valuation of $800m, three years after UC-RNT Fund supplied $25m to the wellness services provider.
University of Bristol-founded Psiquantum has reportedly scooped funding from backers including an Andy Rubin fund as it looks to develop silicon-powered quantum computers.
Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.
Andreessen Horowitz has led a $400m round for the data preparation software provider based on UC Berkeley research, more than doubling its valuation to $6.2bn in eight months.
Cambridge Innovation Capital has returned a second time to back a $240m series C for CMR Surgical, helping bring the surgical robotics company's total funding to $386m.
Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.
Cash Capital has contributed to a a series C round for medical supplies provider GKHT, established as an affiliate of the Chinese Academy of Sciences-owned Osic Holding Group.
University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.